Nitroglycerin

hypoxia inducible factor 1 subunit alpha ; Homo sapiens







9 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35157994 Nitroglycerin Plus Whole Intracranial Radiation Therapy for Brain Metastases in Non-Small Cell Lung Cancer Patients: A Randomized, Open-Label, Phase 2 Clinical Trial. 2022 Feb 12 2
2 31912870 Inhibition of hypoxia-inducible factor 1α accumulation by glyceryl trinitrate and cyclic guanosine monophosphate. 2020 Jan 31 4
3 26347109 A randomized phase II study comparing paclitaxel-carboplatin-bevacizumab with or without nitroglycerin patches in patients with stage IV nonsquamous nonsmall-cell lung cancer: NVALT12 (NCT01171170)†. 2015 Nov 2
4 26435741 Repurposing Drugs in Oncology (ReDO)-nitroglycerin as an anti-cancer agent. 2015 1
5 24336068 A mechanism of hypoxia-mediated escape from adaptive immunity in cancer cells. 2014 Feb 1 2
6 24836861 Phase II study. Concurrent chemotherapy and radiotherapy with nitroglycerin in locally advanced non-small cell lung cancer. 2014 May 2
7 21641407 Glyceryl trinitrate inhibits hypoxia-induced release of soluble fms-like tyrosine kinase-1 and endoglin from placental tissues. 2011 Jun 1
8 17121895 Nitroglycerin treatment may enhance chemosensitivity to docetaxel and carboplatin in patients with lung adenocarcinoma. 2006 Nov 15 3
9 15465035 The inhibitory effect of sodium nitroprusside on HIF-1 activation is not dependent on nitric oxide-soluble guanylyl cyclase pathway. 2004 Nov 5 2